Aspira Pathlab & Diagnostics Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Aspira Pathlab & Diagnostics Quarterly Results    (APDL)

Here are the latest quarterly results of Aspira Pathlab & Diagnostics . For more details, see the Aspira Pathlab & Diagnostics financial fact sheet and Aspira Pathlab & Diagnostics share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Aspira Pathlab & Diagnostics Quarterly Results

No. of Mths
Qtr. Ending
3
Sep-19
*
3
Dec-19
*
3
Mar-20
*
3
Jun-20
*
3
Sep-20
*
3
Dec-20
*
3
Mar-21
*
3
Jun-21
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m2322201554424159 
Other income Rs m11111100 
Turnover Rs m2423201654434159 
Expenses Rs m2626271635343135 
Gross profit Rs m-3-4-7-11981024 
Depreciation Rs m44444444 
Interest Rs m23222221 
Profit before tax Rs m-9-10-13-6133420 
Tax Rs m00000000 
Profit after tax Rs m-9-10-13-6133420 
Gross profit margin %-12.3-17.3-36.7-6.434.718.523.741.3 
Effective tax rate %0.00.00.00.00.00.00.00.0 
Net profit margin %-37.0-45.9-66.8-41.424.76.110.434.0 
Diluted EPS Rs -0.8 -1.0 -1.3 -0.6 1.3 0.2 0.4 1.9  
Diluted EPS (TTM) Rs NA -4.1 -4.1 -3.7 -1.6 -0.3 1.3 3.9  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster

More Hospital & Healthcare Services Company Quarterly Results:   GANGA PHARMACEUTICALS  DESH RAKSHAK  ALBERT DAVID  IPCA LABS  DECCAN HEALTH CARE  

Compare ASPIRA PATHLAB & DIAGNOSTICS With:   GANGA PHARMACEUTICALS  DESH RAKSHAK  ALBERT DAVID  IPCA LABS  DECCAN HEALTH CARE  



Today's Market

Sensex Opens Above 62,000 Mark, Nifty Nears 18,600; L&T and Bharti Airtel Top Gainers(09:30 am)

Asian share markets opened higher today after Wall Street indices ended mostly up and with investors awaiting corporate earnings.

Views on news

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Apollo Hospitals' Shares Rally Over 5%, Hit Record-High on Strong Results (Views On News)

Aug 16, 2021

The company reported a 73% YoY increase in revenue driven by an uptick in the hospital and pharmacy business.

J B Chemicals & Pharma's Decent Performance Puts Stock in Focus (Views On News)

Aug 13, 2021

The company seeks to expand the market for prescription lozenges with new launches this year.

More Views on News

Most Popular

Is it Time to Switch from Tata Power to NTPC? (Profit Hunter)

Oct 11, 2021

Given the huge run up in Tata Power, does it make sense to switch to NTPC?

This Proxy EV Stock Just got a Power Crisis Boost (Profit Hunter)

Oct 8, 2021

After months of research, I've come across few stocks that excite me far more than the mainstream electric vehicle companies.

Rs 1 Lakh Invested in These Cryptos at the Start of 2021 Became Rs... (Views On News)

Oct 8, 2021

These cryptos would have multiplied investors' wealth by as much as 10,000% in just nine months.

Top 5 'Digital India' Stocks (Views On News)

Oct 6, 2021

These companies are leading the Government's US$1 tn 'Digital India' initiative.

5 Exciting 'Unlisted' Companies and How to Play Them (Views On News)

Oct 7, 2021

Here's how you can invest in some of the most exciting start-ups of the decade.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ASPIRA PATHLAB & DIAGNOSTICS SHARE PRICE


Oct 19, 2021 01:10 PM

TRACK ASPIRA PATHLAB & DIAGNOSTICS

  • Track your investment in ASPIRA PATHLAB & DIAGNOSTICS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ASPIRA PATHLAB & DIAGNOSTICS

ASPIRA PATHLAB & DIAGNOSTICS - KAYA COMPARISON

COMPARE ASPIRA PATHLAB & DIAGNOSTICS WITH

MARKET STATS